| Literature DB >> 29098882 |
Masoud Farshbaf1,2,3, Roya Salehi2, Nasim Annabi4,5,6, Rovshan Khalilov7,8, Abolfazl Akbarzadeh3,9,10, Soodabeh Davaran11.
Abstract
In the current study, we proposed a facile method for fabrication of multifunctional pH- and thermo-sensitive magnetic nanocomposites (MNCs) as a theranostic agent for using in targeted drug delivery and magnetic resonance imaging (MRI). To this end, we decorated Fe3O4 magnetic nanoparticles (MNPs) with N,N-dimethylaminoethyl methacrylate (DMAEMA) and N-isopropylacrylamide (NIPAAm), best known for their pH- and thermo-sensitive properties, respectively. We also conjugated mesoporous silica nanoparticles (MSNs) to polymer matrix acting as drug container to enhance the drug encapsulation efficacy. Methotroxate (MTX) as a model drug was successfully loaded in MNCs (M-MNCs) via surface adsorption onto MSNs and electrostatic interaction between drug and carrier. The pH- and temperature-triggered release of MTX was concluded through the evaluation of in vitro release at both physiological and simulated tumor tissue conditions. Based on in vitro cytotoxicity assay results, M-MNCs significantly revealed higher antitumor activity compared to free MTX. In vitro MR susceptibility experiment showed that M-MNCs relatively possessed high transverse relaxivity (r2) of about 0.15 mM-1·ms-1 and a linear relationship between the transverse relaxation rate (R2) and the Fe concentration in the M-MNCs was also demonstrated. Therefore, the designed MNCs can potentially become smart drug carrier, while they also can be promising MRI negative contrast agent.Entities:
Keywords: MRI contrast agent; Theranostic nanomedicine; dual-responsive drug delivery; lung cancer; magnetic nanoparticles; methotrexate
Mesh:
Substances:
Year: 2017 PMID: 29098882 DOI: 10.1080/03639045.2017.1397686
Source DB: PubMed Journal: Drug Dev Ind Pharm ISSN: 0363-9045 Impact factor: 3.225